Iovance Biotherapeutics (IOVA) EPS (Weighted Average and Diluted) (2023 - 2025)
Historic EPS (Weighted Average and Diluted) for Iovance Biotherapeutics (IOVA) over the last 5 years, with Q2 2025 value amounting to -$0.33.
- Iovance Biotherapeutics' EPS (Weighted Average and Diluted) rose 294.12% to -$0.33 in Q2 2025 from the same period last year, while for Jun 2025 it was -$1.22, marking a year-over-year increase of 2694.61%. This contributed to the annual value of -$1283.9 for FY2024, which is 6783193.24% down from last year.
- According to the latest figures from Q2 2025, Iovance Biotherapeutics' EPS (Weighted Average and Diluted) is -$0.33, which was up 294.12% from -$0.36 recorded in Q1 2025.
- Over the past 5 years, Iovance Biotherapeutics' EPS (Weighted Average and Diluted) peaked at -$0.33 during Q2 2025, and registered a low of -$275.47 during Q3 2024.
- In the last 3 years, Iovance Biotherapeutics' EPS (Weighted Average and Diluted) had a median value of -$0.45 in 2023 and averaged -$54.99.
- The largest annual percentage gain for Iovance Biotherapeutics' EPS (Weighted Average and Diluted) in the last 5 years was 2765.96% (2024), contrasted with its biggest fall of 6013474.32% (2024).
- Quarter analysis of 3 years shows Iovance Biotherapeutics' EPS (Weighted Average and Diluted) stood at -$0.45 in 2023, then plummeted by 60134.74% to -$271.06 in 2024, then skyrocketed by 99.88% to -$0.33 in 2025.
- Its last three reported values are -$0.33 in Q2 2025, -$0.36 for Q1 2025, and -$271.06 during Q4 2024.